Shareholding disclosure

Idorsia Pharmaceuticals Ltd

Declared position

29.24%

Threshold

Crossed upwards

Timeline

Published

27.10.2020

Transaction

23.10.2020

Voting rights breakdown

Voting rights acquired29.24%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAKAQ00067

Beneficial owner

Idorsia Pharmaceuticals Ltd

Declared address

Idorsia Pharmaceuticals Ltd, 4123 Allschwil

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open